Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

Explore Cathie Wood's latest investment insights on the convergence of artificial intelligence in shaping the future, as ...

ARK Invest's 13F portfolio value increased by ~10% to ~$12B this quarter. Check out the top holdings and new stakes of the ...

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...

Ark Invest CEO and CIO Cathie Wood joins 'Squawk Box' to discuss her big ideas of 2025, investing in AI technology, impact of ...

Cathie Wood claims AI costs could drop after DeepSeek. Will Solana, Near Protocol, or IntelMarkets benefit the most from this ...

Ark Invest’s purchase of Iridium Communications Inc IRDM shares via ARK Space Exploration & Innovation ETF ARKX aligns with ...

Cathie Wood, the CEO of Ark Investment Management, has made headlines recently with significant trades in the tech sector, ...